She took Ozempic, now she can't eat without vomiting. Lawsuit claims the drug made her ill [USA TODAY]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: USA TODAY
But the antidiabetic pills Filmore was taking weren't enough to bring her blood sugar down to a healthy level. Her doctor told her that Ozempic, a medication to treat Type 2 diabetes, could help. So Filmore, a 55-year-old grandmother of seven and account coordinator from Columbus, Ohio, bit the bullet. Now more than three years later, Filmore's doctor has diagnosed her with , or stomach paralysis – a potential side effect of the drug. Six months after stopping the injections, Filmore still can't keep food down. Normally, the stomach contracts to propel food through the digestive tract. With gastroparesis, the stomach muscles are paralyzed, so food lingers in the stomach for longer than it should, which results in vomiting or diarrhea. “You never know what will set it off,” said Filmore, who says she has to run to the bathroom within minutes of starting a meal. She's one of thousands of plaintiffs across the country claiming in a federal lawsuit that Ozempic, Mounjaro and ot
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- WeightWatchers CEO Sima Sistani is leaving the company [Yahoo! Finance]Yahoo! Finance
- PFE vs. NVO: Which Stock Is the Better Value Option? [Yahoo! Finance]Yahoo! Finance
- Novo Nordisk's Wegovy-Fueled Gains Fading as Analyst Doubts Grow [Yahoo! Finance]Yahoo! Finance
- Prediction: Eli Lilly Will Dominate the Billion-Dollar Weight Loss Drug Market for This Key Reason [Yahoo! Finance]Yahoo! Finance
- Compounding pharmacies caught in counterfeit controversy [Yahoo! Finance]Yahoo! Finance
NVO
Earnings
- 8/8/24 - Beat
NVO
Sec Filings
- 9/24/24 - Form 6-K
- 9/20/24 - Form 6-K
- 9/16/24 - Form 6-K
- NVO's page on the SEC website